Antibiotic identified that reduces infection risk in young leukemia patientsSeptember 14, 2017
St. Jude Children's Research Hospital researchers have identified an antibiotic that significantly reduced the odds of infections in children starting treatment for acute lymphoblastic leukemia (ALL) without an apparent increase in antibiotic resistance. The research appears today in the journal Clinical Infectious Diseases.
The study was the largest yet focused on the safety and efficacy of proactive antibiotic therapy to prevent infections in pediatric ALL patients during induction therapy. These early weeks of chemotherapy often lead to a drop in white blood cells known as neutropenia that leaves patients at risk for life-threatening infections that can delay cancer treatment. Nationwide, up to 4 percent of young ALL patients die from treatment-related infections.
"This research provides the first major evidence supporting targeted use of antibacterial prophylaxis for at-risk pediatric ALL patients, particularly use of the broad-spectrum antibiotic levofloxacin," said lead author Joshua Wolf, M.D., an assistant member of the St. Jude Department of Infectious Diseases. The findings have been incorporated into Total Therapy XVII, the current St. Jude clinical trial for children and adolescents newly diagnosed with ALL.
Researchers reported that preventive therapy with levofloxacin or other antibiotics reduced the odds of infection, including fevers and bloodstream infections, by 70 percent or more in ALL patients with neutropenia during induction therapy. Levofloxacin also reduced patients' odds of antibiotic-associated infection with Clostridium difficile by 95 percent or more. Hospital-acquired C. difficile infection is associated with a nearly seven-fold increased risk of death in children.
Levofloxacin reduced patient exposure to front-line antibiotics like vancomycin and cefepime. These antibiotics are needed if patients develop infections during therapy. Researchers said the reduced exposure might explain why levofloxacin reduced odds of infection with C. difficile. A.ntibiotic treatment is a risk factor for C. difficile infection.
"Prophylactic antibiotic therapy with levofloxacin is routine for at-risk adult ALL patients, but it has remained controversial in children," Wolf said. "Until this study, evidence supporting the safety and efficacy of prophylactic antibiotic therapy in children with ALL has been sparse."
Physicians have also worried that proactive antibiotic treatment in children would promote drug resistance, particularly to antibiotics needed to treat life-threatening infection in patients who become infected.
The study included 344 St. Jude patients enrolled in the St. Jude Total XVI clinical trial for patients newly diagnosed with ALL. Patients were enrolled from 2007 to 2016. Until July 2014, patients received prophylactic antibiotic therapy at the discretion of their physicians. Beginning in August 2014, hospital treatment guidelines changed to recommend prophylactic levofloxacin therapy during induction therapy for ALL patients who develop neutropenia expected to last at least seven days.
Wolf and his colleagues used the change to compare infection rates and other questions in 173 patients who received no preventive antibiotics; 69 patients treated prophylactically with levofloxacin; and 102 patients who received other prophylactic antibiotics, typically cefepime, ciprofloxacin or vancomycin, alone or in combination. Researchers did not include patients with infections that began prior to or early in induction therapy. Investigators also used a statistical method called propensity score-weighting to control for differences among the patient groups.
Researchers reported that patients with neutropenia who received any prophylactic therapy were far less likely than those who did not to develop fever, documented or likely infections, or bloodstream infections.
In contrast, reductions in C. difficile infections occurred only in levofloxacin-treated patients. Levofloxacin belongs to the fluoroquinolone family of antibiotics, which animal studies have suggested might reduce the risk of infection with C. difficile compared with other antibiotics. Levofloxacin was associated with reduced exposure to other antibiotics, including antibiotics that were essential for treatment if infections did occur. The reduction in exposure to other antibiotics may partly explain why C. difficile infections declined in levofloxacin-treated patients, Wolf said.
Meanwhile, antibiotic resistance did not significantly increase despite greater use of levofloxacin to prevent infections. "We are cautiously optimistic that any impact of levofloxacin on antibacterial resistance will be balanced by the reduction in use of other antibiotics, but long-term monitoring antibiotic resistance patterns in young ALL patients will be needed to prove this," Wolf said.
The study was funded in part by grants (CA21765, CA3640126S1, GM92666) from the National Institutes of Health and ALSAC, the fundraising and awareness organization of St. Jude.
St. Jude Children's Research Hospital
Related Antibiotics Articles:
Canadian researchers have generated both novel and existing antibiotic resistance mechanisms on experimental farmland, by exposing the soil to specific antibiotics.
UCSB biologists correct a flaw in the way bacterial susceptibility to these drugs is tested.
Fungi are a potential goldmine for the production of pharmaceuticals.
The growth of bacteria can be stimulated by antibiotics, scientists at the University of Exeter have discovered.
The ECDC's latest data on antimicrobial resistance and consumption shows that in 2015, antibiotic resistance continued to increase for most bacteria and antibiotics under surveillance.
Two widely prescribed antibiotics -- chloramphenicol and linezolid -- may fight bacteria in a different way from what scientists and doctors thought for years, University of Illinois at Chicago researchers have found.
News release describes efforts to address inappropriate antibiotic prescribing in emergency departments and urgent-care centers nationwide, which a JAMA study published this past May found rates as high as 50 percent for acute respiratory infections in US emergency departments.
Nine in 10 dairy farmers participating in a new survey from the Royal Association of British Dairy Farmers (RADBF) say that the farming industry must take a proactive lead in the battle against antibiotic resistance.
Antibiotics are advised in most guidelines on diverticulitis, which arises when one or more small pouches in the digestive tract become inflamed or infected.
'Antibiotics and Antibiotic Resistance' from CSHLPress examines the major classes of antibiotics, together with their modes of action and mechanisms of resistance.
Related Antibiotics Reading:
by Jason C. Gallagher (Author), Conan MacDougall (Author)
"This book focuses on key points of basic microbiology and antimicrobial pharmacotherapy and organizes them into a concise guide … must-have antimicrobial reference guide for all medical and pharmacy students." - Lindsay McDonnell, PharmD for Doody's Review Service
Antibiotics Simplified, Fourth Edition is a best-selling, succinct guide designed to bridge knowledge gained in basic sciences courses with clinical practice in infectious diseases. This practical text reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. It also... View Details
Antibiotics: Challenges, Mechanisms, Opportunities
by Christopher Walsh (Author), Timothy Wencewicz (Author)
A chemocentric view of the molecular structures of antibiotics, their origins, actions, and major categories of resistance
Antibiotics: Challenges, Mechanisms, Opportunities focuses on antibiotics as small organic molecules, from both natural and synthetic sources. Understanding the chemical scaffold and functional group structures of the major classes of clinically useful antibiotics is critical to understanding how antibiotics interact selectively with bacterial targets.
This textbook details how classes of antibiotics interact with five known robust... View Details
Antibiotic Essentials 2017
by Burke A. Cunha (Author), Cheston Cunha (Author)
The new edition of this highly successful annual pocket guide presents clinicians with the most recent information in the field of antimicrobial therapy and infectious diseases. Written by recognised experts in infectious disease, this edition discusses serum and urinary spectrum summaries of antibiotics and clinically relevant pharmacokinetics. Completely new sections on Antibiotic Stewardship, IV-to-PO Switch Therapy, and differentiation of colonisation and infection, are also included. Unique features of this book include clinical synopses of common and uncommon infections worldwide,... View Details
EMRA Antibiotic Guide, 17th Edition
by MD Brian J. Levine (Author)
Herbal Antibiotics, 2nd Edition: Natural Alternatives for Treating Drug-resistant Bacteria
by Stephen Harrod Buhner (Author)
With antibiotic-resistant infections on the rise, herbal remedies present a naturally effective alternative to standard antibiotics. Herbal expert Stephen Harrod Buhner explains the roots of antibiotic resistance, explores the value of herbal treatments, and provides in-depth profiles of 30 valuable plants, noting the proper dosages, potential side effects, and contraindications of each. View Details
Antibiotic Basics for Clinicians: The ABCs of Choosing the Right Antibacterial Agent
by Alan R. Hauser MD PhD (Author)
Easy-to-apply set of principles for selecting the right antibiotic
Antibiotic Basics for Clinicians, Second Edition, shows you how to apply your knowledge of pharmacology and microbiology in order to select the appropriate antibiotic. Rather than rely on rote memorization, you’ll learn the underlying rationale for treatment of common infectious diseases and pathogens. The text focuses on antibacterial agents, examining individual antibiotics and antibiotic classes as well as definitive and empiric therapies—providing a... View Details
Antibiotics Pocketcard Set 2016
by H. Hof (Author), R. Knueppel (Author)
Brand new View Details
Miracle Cure: The Creation of Antibiotics and the Birth of Modern Medicine
by William Rosen (Author)
The epic history of how antibiotics were born, saving millions of lives and creating a vast new industry known as Big Pharma.
As late as the 1930s, virtually no drug intended for sickness did any good; doctors could set bones, deliver babies, and offer palliative care. That all changed in less than a generation with the discovery and development of a new category of medicine known as antibiotics. By 1955, the age-old evolutionary relationship between humans and microbes had been transformed, trivializing once-deadly infections.
William Rosen captures this... View Details
MemoCharts Pharmacology: Antibiotics (Review chart)
by Howard Shen (Author)
An updated integrated mini review of antibiotics, illustrated with visually appealing tables and diagrams. A quick visual aide for the course study and board review View Details
by Jason C. Gallagher (Author), Conan MacDougall (Author)
Antibiotics Simplified is included in the 2015 edition of the essential collection of Doody's Core Titles.
Antibiotics Simplified, Third Edition is a best-selling, succinct guide designed to bridge knowledge gained in basic sciences courses with clinical practice in infectious diseases. This practical text reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. It also contains concise Drug Class Reviews with an explanation of the characteristics of various classes of antibacterial drugs and antifungal drugs.
Antibiotics... View Details